They really are falling behind with their TB control.
A survey carried out in the UK explored the use of IGRAs for the diagnosis of LTBI in HIV-positive patients [19]; they were not systematically performed in all departments, not being performed in 22% of the participating clinical departments and only sometimes being performed in 8% of them. The majority of the surveyed centers (63%) use these novel diagnostic techniques, although their application in this cohort of immunocompromised individuals is not totally supported in the present national NICE guidelines. Contrary to expectations and to NICE guidance, when Patel et al. analyzed their overall use in the general population, it was found that the majority of the clinical settings do not (42%) or do with limitation (12%) utilize IGRAs in TST-positive subjects.Link